Canada markets closed

Revance Therapeutics, Inc. (RVNC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.4000+0.1100 (+3.34%)
At close: 04:00PM EDT
3.4000 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 342.87M
Enterprise Value 567.39M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.19
Price/Book (mrq)N/A
Enterprise Value/Revenue 2.42
Enterprise Value/EBITDA -1.95

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3-89.66%
S&P500 52-Week Change 321.08%
52 Week High 337.9800
52 Week Low 33.2100
50-Day Moving Average 35.0432
200-Day Moving Average 310.0955

Share Statistics

Avg Vol (3 month) 31.83M
Avg Vol (10 day) 31.89M
Shares Outstanding 5104.22M
Implied Shares Outstanding 6104.22M
Float 870.71M
% Held by Insiders 18.47%
% Held by Institutions 176.18%
Shares Short (Apr 15, 2024) 411.63M
Short Ratio (Apr 15, 2024) 47.55
Short % of Float (Apr 15, 2024) 412.81%
Short % of Shares Outstanding (Apr 15, 2024) 411.16%
Shares Short (prior month Mar 15, 2024) 410.87M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -138.43%
Operating Margin (ttm)-73.19%

Management Effectiveness

Return on Assets (ttm)-26.02%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)234.04M
Revenue Per Share (ttm)2.77
Quarterly Revenue Growth (yoy)39.80%
Gross Profit (ttm)N/A
EBITDA -207.03M
Net Income Avi to Common (ttm)-323.99M
Diluted EPS (ttm)-3.8300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)253.92M
Total Cash Per Share (mrq)2.88
Total Debt (mrq)478.43M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.80
Book Value Per Share (mrq)-1.72

Cash Flow Statement

Operating Cash Flow (ttm)-216.58M
Levered Free Cash Flow (ttm)-134.99M